Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6T3O

Crystal structure of the human myomesin domain 10

Summary for 6T3O
Entry DOI10.2210/pdb6t3o/pdb
DescriptorMyomesin-1, AZIDE ION (3 entities in total)
Functional Keywordssmall protein domain, scaffold structure, contractile protein
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight15437.46
Authors
Duskova, J.,Petrokova, H.,Maly, P. (deposition date: 2019-10-11, release date: 2021-03-17, Last modification date: 2024-01-24)
Primary citationKuchar, M.,Kosztyu, P.,Daniel Liskova, V.,Cerny, J.,Petrokova, H.,Vroblova, E.,Maly, M.,Vankova, L.,Krupka, M.,Raskova Kafkova, L.,Turanek Knotigova, P.,Duskova, J.,Dohnalek, J.,Masek, J.,Turanek, J.,Raska, M.,Maly, P.
Myomedin scaffold variants targeted to 10E8 HIV-1 broadly neutralizing antibody mimic gp41 epitope and elicit HIV-1 virus-neutralizing sera in mice.
Virulence, 12:1271-1287, 2021
Cited by
PubMed Abstract: One of the proposed strategies for the development of a more efficient HIV-1 vaccine is based on the identification of proteins binding to a paratope of chosen broadly neutralizing antibody (bNAb) that will mimic cognate HIV-1 Env (glyco)protein epitope and could be used as potent immunogens for induction of protective virus-neutralizing antibodies in the immunized individuals. To verify this "non-cognate ligand" concept, we developed a highly complex combinatorial library designed on a scaffold of human myomesin-1 protein domain and selected proteins called Myomedins specifically binding to variable regions of HIV-1 broadly neutralizing antibody 10E8. Immunization of mice with these Myomedin variants elicited the production of HIV-1 Env-specific antibodies. Hyperimmune sera bound to Env pseudotyped viruses and weakly/moderately neutralized 54% of tested clade A, B, C, and AE pseudotyped viruses variants . These results demonstrate that Myomedin variants have the potential to mimic Env epitopes and could be used as potential HIV-1 vaccine components.
PubMed: 33993840
DOI: 10.1080/21505594.2021.1920251
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.8 Å)
Structure validation

226707

건을2024-10-30부터공개중

PDB statisticsPDBj update infoContact PDBjnumon